ASX:ALX Atlas Arteria (ALX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Atlas Arteria Stock (ASX:ALX) 30 days 90 days 365 days Advanced Chart Get Atlas Arteria alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume3.69 million shsAverage VolumeN/AMarket Capitalization$7.33 billionP/E Ratio31.31Dividend Yield7.92%Price TargetN/AConsensus RatingN/A Company OverviewAtlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States. The company was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia.Read More… Receive ALX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter. Email Address ALX Stock News HeadlinesAtlas Arteria records 6.1% jump in Q1 toll revenueApril 24, 2025 | msn.comASX Market Close: Index pares gains to close flat | March 25, 2025March 25, 2025 | msn.comBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.June 13, 2025 | Crypto 101 Media (Ad)Jefferies Sticks to Their Buy Rating for Atlas Arteria (MAQAF)March 3, 2025 | markets.businessinsider.comCiti Sticks to Its Buy Rating for Atlas Arteria (MAQAF)February 26, 2025 | markets.businessinsider.comAtlas Arteria tries to claw back $20b in lost returns on US toll roadFebruary 26, 2025 | afr.comRBC Capital Keeps Their Hold Rating on Atlas Arteria (MAQAF)February 8, 2025 | markets.businessinsider.comJefferies Reaffirms Their Buy Rating on Atlas Arteria (MAQAF)January 30, 2025 | markets.businessinsider.comSee More Headlines ALX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Atlas Arteria own? Based on aggregate information from My MarketBeat watchlists, some other companies that Atlas Arteria investors own include Adairs (ADH), AMA Group (AMA), ANZ Group (ANZ), Commonwealth Bank of Australia (CBA), Fortescue (FMG), Gilead Sciences (GILD) and Company Calendar Ex-Dividend for 4/3 Dividend3/24/2025Record date for 4/3 Dividend4/03/2025Dividend Payable4/03/2025Today6/13/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry Infrastructure Operations Sub-IndustryTrading Current SymbolASX:ALX CIKN/A Webwww.atlasarteria.com Phone61 2 8232 7455FaxN/AEmployees70Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.21 Trailing P/E Ratio31.31 Forward P/E RatioN/A P/E Growth0.31Net Income$300.20 million Net Margins167.02% Pretax MarginN/A Return on Equity3.79% Return on Assets-0.06% Debt Debt-to-Equity Ratio27.23 Current Ratio2.26 Quick Ratio1.77 Sales & Book Value Annual Sales$140.10 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.65 Book ValueA$4.21 per share Price / BookN/AMiscellaneous Outstanding Shares1,450,000,000Free FloatN/AMarket Cap$7.33 billion OptionableNot Optionable Beta0.78 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (ASX:ALX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atlas Arteria Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Atlas Arteria With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.